The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards
Summary: Prevention of hazardous drug exposure is essential in averting unnecessary health risks to health care workers (HCW). To address the risk to HCWs when handling hazardous drugs, engineering controls can be utilized to reduce the exposure. A closed system transfer device (CSTD) was introduced...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Infection Prevention in Practice |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259008892300001X |
| _version_ | 1797900665207390208 |
|---|---|
| author | Josephine Fox Ashley Rumsey Rebecca Rojek Kathleen Rensing Heather Gasama Lydia Grimes-Jenkins Helen Wood Erik R. Dubberke David K. Warren |
| author_facet | Josephine Fox Ashley Rumsey Rebecca Rojek Kathleen Rensing Heather Gasama Lydia Grimes-Jenkins Helen Wood Erik R. Dubberke David K. Warren |
| author_sort | Josephine Fox |
| collection | DOAJ |
| description | Summary: Prevention of hazardous drug exposure is essential in averting unnecessary health risks to health care workers (HCW). To address the risk to HCWs when handling hazardous drugs, engineering controls can be utilized to reduce the exposure. A closed system transfer device (CSTD) was introduced for hazardous drugs administration in 6 oncology wards; this new CSTD was associated with a significant increase in CLABSI rates. |
| first_indexed | 2024-04-10T08:49:35Z |
| format | Article |
| id | doaj.art-e4785839bcaf4a4e89d30c2520d3aab4 |
| institution | Directory Open Access Journal |
| issn | 2590-0889 |
| language | English |
| last_indexed | 2024-04-10T08:49:35Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Infection Prevention in Practice |
| spelling | doaj.art-e4785839bcaf4a4e89d30c2520d3aab42023-02-22T04:32:09ZengElsevierInfection Prevention in Practice2590-08892023-03-0151100268The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wardsJosephine Fox0Ashley Rumsey1Rebecca Rojek2Kathleen Rensing3Heather Gasama4Lydia Grimes-Jenkins5Helen Wood6Erik R. Dubberke7David K. Warren8Barnes-Jewish Hospital, St. Louis, Missouri, USA; Corresponding author. Barnes-Jewish Hospital, Mailstop 90-29-926, 4590, Children's Place, St. Louis MO 63110, USABarnes-Jewish Hospital, St. Louis, Missouri, USABarnes-Jewish Hospital, St. Louis, Missouri, USABarnes-Jewish Hospital, St. Louis, Missouri, USABarnes-Jewish Hospital, St. Louis, Missouri, USABarnes-Jewish Hospital, St. Louis, Missouri, USABarnes-Jewish Hospital, St. Louis, Missouri, USAWashington University School of Medicine, St. Louis, Missouri, USAWashington University School of Medicine, St. Louis, Missouri, USASummary: Prevention of hazardous drug exposure is essential in averting unnecessary health risks to health care workers (HCW). To address the risk to HCWs when handling hazardous drugs, engineering controls can be utilized to reduce the exposure. A closed system transfer device (CSTD) was introduced for hazardous drugs administration in 6 oncology wards; this new CSTD was associated with a significant increase in CLABSI rates.http://www.sciencedirect.com/science/article/pii/S259008892300001XCentral line associated bloodstream infectionClosed system transfer deviceOncologySurveillanceBloodstream infection |
| spellingShingle | Josephine Fox Ashley Rumsey Rebecca Rojek Kathleen Rensing Heather Gasama Lydia Grimes-Jenkins Helen Wood Erik R. Dubberke David K. Warren The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards Infection Prevention in Practice Central line associated bloodstream infection Closed system transfer device Oncology Surveillance Bloodstream infection |
| title | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| title_full | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| title_fullStr | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| title_full_unstemmed | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| title_short | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| title_sort | impact on central line associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards |
| topic | Central line associated bloodstream infection Closed system transfer device Oncology Surveillance Bloodstream infection |
| url | http://www.sciencedirect.com/science/article/pii/S259008892300001X |
| work_keys_str_mv | AT josephinefox theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT ashleyrumsey theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT rebeccarojek theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT kathleenrensing theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT heathergasama theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT lydiagrimesjenkins theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT helenwood theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT erikrdubberke theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT davidkwarren theimpactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT josephinefox impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT ashleyrumsey impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT rebeccarojek impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT kathleenrensing impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT heathergasama impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT lydiagrimesjenkins impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT helenwood impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT erikrdubberke impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards AT davidkwarren impactoncentrallineassociatedbloodstreaminfectionratesfollowingtheintroductionofaclosedsystemtransferdeviceinoncologywards |